Dr Gareth Parkes

Education

Queens’ College Cambridge, QMUL, King’s College London.

Training

Gareth trained at Cambridge University and Bart’s & the London and was awarded a PhD at King’s College London.

Certifications

MA, MBBS, PhD, FRCP

BIO

Gareth trained at Cambridge University and Bart’s & the London and was awarded a PhD at King’s College London. He now works as the Clinical Lead for Gastroenterology at the Royal London Hospital and is a core member of its IBD team. In 2018 he co-founded Ampersand Health and developed MyIBD Care with Bu Hayee from Kings and Nader Alaghband with a goal to make life easier for patients with IBD. His interests include the role of digital therapeutics, clinical trials in IBD, the role of the microbiota and probiotics and the use of technology in IBD OPD. Gareth sits on the British Society of Gastroenterology IBD committee, co-authored the current UK guidelines and has a number of publications in the field of IBS and IBD.

PROFESSIONAL ACCOMPLISHMENTS

2010 – PhD King’s College London
2014 – Consultant Gastroenterologist Royal London Hospital Barts Health NHS Trust
2017 – Cofounded Ampersand Health
2017-2020 + 2022 to date – IBD Section committee member BSG
2018 – Clinical Lead for Gastroenterology

AFFILIATIONS

Royal College of Physicians London, British Society of Gastroenterology, European Crohn’s and Colitis Organisation.

RECENT PUBLICATIONS

Ampersand Health Selected for PharmStars Accelerator Programme

06 Dec 2023

Ampersand Health, alongside 10 other leading health tech innovations, has successfully graduated from PharmStars.

US Researchers from University of Michigan & University of Minnesota Evaluate Behaviour Change Techniques in IBD Management Apps

05 Dec 2023

Researchers from The University of Michigan and University of Minnesota Medical School conducted a study titled "Use of Behavior Change Techniques and Quality...

Researchers from Mount Sinai Conduct Study Including My IBD Care

20 Sep 2023

Researchers from Mount Sinai, one of the largest teaching hospitals in the US, conducted a study on digital support tools for people with IBD, including My IBD...

Ampersand Health Featured in BMJ

22 Jun 2023

Our work on patient initiated follow-up using our My IBD Care app, along with self-monitoring of calprotectin through our CalproSmart™ ™ integration,...

Hull University Teaching Hospitals Study on My IBD Care & Calprotectin Testing

20 Jun 2023

Hull University Teaching Hospitals conducted a study on incorporating Ampersand’s patient-facing app and home calprotectin based PIFU and monitoring in IBD...

My IBD Care

My Arthritis